Protocol Ledger

NCT05316701 · Phase III · ACTIVE NOT RECRUITING

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Interventional Phase III clinical trial protocol NCT05316701 sponsored by Orca Biosystems in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-06-21 Enrollment: 187 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05316701
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)187 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05316701
Protocol FieldVerified Registry Value
NCT IdentifierNCT05316701
Consolidated Lead SponsorOrca Biosystems
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment187 participants (ACTUAL)
Registered Start Date2022-06-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI